featured
Outcome Without Adjuvant Systemic Treatment in Stage I ER+/HER2− Breast Cancer Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Outcome without any adjuvant systemic treatment in stage I ER+/HER2- breast cancer patients included in the MINDACT trial
Ann. Oncol 2021 Nov 30;[EPub Ahead of Print], JMNL Cardozo, D Byng, CA Drukker, MK Schmidt, MA Binuya, LJV' Veer, F Cardoso, M Piccart, CH Smorenburg, C Poncet, EJT RutgersFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.